Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells (Q21245299)

18 August 2022

Zhaoshun Jiang

2

Zhaoshun

Jiang

1 reference

18 August 2022

Tingbao Zhao

3

Tingbao

Zhao

1 reference

18 August 2022

Mingliang Ye

4

Mingliang

Ye

1 reference

18 August 2022

Chengjin Hu

5

Chengjin

Hu

1 reference

18 August 2022

Zhaohui Yin

6

Zhaohui

Yin

1 reference

18 August 2022

Heng Li

7

Heng

Li

1 reference

18 August 2022

Ye Zhang

8

Ye

Zhang

1 reference

18 August 2022

Yalin Diao

9

Yalin

Diao

1 reference

18 August 2022

Yunxiang Li

10

Yunxiang

Li

1 reference

18 August 2022

Yingjian Chen

11

Yingjian

Chen

1 reference

18 August 2022

Xiaoming Sun

12

Xiaoming

Sun

1 reference

18 August 2022

Mary Beth Fisk

13

Mary Beth

Fisk

1 reference

18 August 2022

Randal Skidgel

14

Randal

Skidgel

1 reference

18 August 2022

Mark Holterman

15

Mark

Holterman

1 reference

18 August 2022

Bellur Prabhakar

16

Bellur

Prabhakar

1 reference

18 August 2022

Theodore Mazzone

17

Theodore

Mazzone

1 reference

https://scigraph.springernature.com/pub.10.1186/1741-7015-10-3

18 August 2022

language of work or name

English

0 references

publication date

2012

0 references

published in

BMC Medicine

0 references

volume

10

0 references

page(s)

3

0 references

issue

1

0 references

exact match

0 references

cites work

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Genetics, pathogenesis and clinical interventions in type 1 diabetes

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

TGF-beta: a master of all T cell trades

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Mechanisms of foxp3+ T regulatory cell-mediated suppression

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Mesenchymal stem cells in health and disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Regulatory T cells and Foxp3

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Molecular mechanisms of T-cell tolerance.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Control of central and peripheral tolerance by Aire

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Type 1 diabetes: etiology, immunology, and therapeutic strategies

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Human cord blood stem cells and the journey to a cure for type 1 diabetes

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Immunopathology of the human pancreas in type-I diabetes

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Stem cell therapy for type 1 diabetes mellitus

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

c-Rel: a pioneer in directing regulatory T-cell lineage commitment?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

GAD treatment and insulin secretion in recent-onset type 1 diabetes

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

T regulatory cells in autoimmune diabetes: past challenges, future prospects

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3322343

Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells

27 September 2017

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-3

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-3

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-3

Pancreatic β-cell neogenesis by direct conversion from mature α-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-3

A unique human blood-derived cell population displays high potential for producing insulin

21 January 2018

1 reference

12 December 2020

Immunology. Regulatory T cells get their chance to shine

1 reference

12 December 2020

Arresting type 1 diabetes after diagnosis: GAD is not enough

1 reference

12 December 2020

Anti-CD3 antibodies for type 1 diabetes: beyond expectations

1 reference

12 December 2020

Clinical studies. Trying to reset the clock on type 1 diabetes

1 reference

12 December 2020

Identifiers

DOI

10.1186/1741-7015-10-3

1 reference

2340083

0 references

2340083

1 reference

1 reference

1 reference